跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Maxtaxel-20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Maxtaxel-20
Approved
STANDARD
Maxtaxel-20
United Biotech Pvt. Limited.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
18c30cf889d828e3
Company
United Biotech Pvt. Limited.
Type
Standard
Approval Details
Approval Id
18c30cf889d828e3
Drug Approval Philippines Name
Maxtaxel-20
Product Name
Maxtaxel-20
Registration Number
DRP-15223
Brand Name
Maxtaxel-20
Generic Name
Docetaxel (as trihydrate)
Dosage Form
Concentrate Solution for Injection. (IV Infusion)
Dosage Strength
20 mg/0.5 mL
Manufacturer
United Biotech Pvt. Limited.
Importer
Dreamax Incorporated
Distributor
Dreamax Incorporated
Issuance Date
29 May 2024
Expiry Date
29 May 2029
Pharmacologic Category
Antineoplastic Agent (Taxane)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
18c30cf889d828e3
Type
Standard
Back to Philippines FDA Approvals